资产负债表（KalVista Pharmaceuticals Inc）
| 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|
| 截止日期 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 | 2022-10-31 | 2022-07-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 0430 | 0430 | 0430 | 0430 | 0430 | 0430 | 0430 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | |||||||
| 现金及现金等价物(元) | 23,056,000.00 | 57,666,000.00 | 49,409,000.00 | 56,238,000.00 | 85,049,000.00 | 38,585,000.00 | 37,863,000.00 |
| 预付款项及其他应收款流动(元) | 28,517,000.00 | 25,434,000.00 | 26,585,000.00 | 22,951,000.00 | 20,448,000.00 | 28,943,000.00 | 11,084,000.00 |
| 可收回本期税项(元) | - | - | - | - | - | - | 17,248,000.00 |
| 短期投资(元) | 52,530,000.00 | 45,506,000.00 | 73,848,000.00 | 93,137,000.00 | 86,636,000.00 | 83,688,000.00 | 104,212,000.00 |
| 流动资产合计(元) | 104,103,000.00 | 128,606,000.00 | 149,842,000.00 | 172,326,000.00 | 192,133,000.00 | 151,216,000.00 | 170,407,000.00 |
| 非流动资产： | |||||||
| 物业、厂房及设备(元) | 2,423,000.00 | 2,502,000.00 | 2,813,000.00 | 2,948,000.00 | 3,037,000.00 | 3,060,000.00 | 3,030,000.00 |
| 非流动资产其他项目(元) | 7,442,000.00 | 7,635,000.00 | 7,677,000.00 | 7,928,000.00 | 8,298,000.00 | 8,562,000.00 | 8,882,000.00 |
| 非流动资产合计(元) | 9,865,000.00 | 10,137,000.00 | 10,490,000.00 | 10,876,000.00 | 11,335,000.00 | 11,622,000.00 | 11,912,000.00 |
| 总资产(元) | 113,968,000.00 | 138,743,000.00 | 160,332,000.00 | 183,202,000.00 | 203,468,000.00 | 162,838,000.00 | 182,319,000.00 |
| 流动负债： | |||||||
| 融资租赁负债流动(元) | 1,187,000.00 | 1,148,000.00 | 1,122,000.00 | 1,087,000.00 | 1,057,000.00 | 1,026,000.00 | 997,000.00 |
| 应付账款及票据(元) | 3,101,000.00 | 4,896,000.00 | 5,060,000.00 | 4,817,000.00 | 1,698,000.00 | 3,384,000.00 | 2,908,000.00 |
| 其他应付款及应计费用(元) | 14,840,000.00 | 11,707,000.00 | 7,950,000.00 | 9,128,000.00 | 8,851,000.00 | 6,910,000.00 | 5,828,000.00 |
| 流动负债合计(元) | 19,128,000.00 | 17,751,000.00 | 14,132,000.00 | 15,032,000.00 | 11,606,000.00 | 11,320,000.00 | 9,733,000.00 |
| 非流动负债： | |||||||
| 融资租赁负债非流动(元) | 6,257,000.00 | 6,546,000.00 | 6,865,000.00 | 7,145,000.00 | 7,421,000.00 | 7,705,000.00 | 8,014,000.00 |
| 非流动负债合计(元) | 6,257,000.00 | 6,546,000.00 | 6,865,000.00 | 7,145,000.00 | 7,421,000.00 | 7,705,000.00 | 8,014,000.00 |
| 总负债(元) | 25,385,000.00 | 24,297,000.00 | 20,997,000.00 | 22,177,000.00 | 19,027,000.00 | 19,025,000.00 | 17,747,000.00 |
| 股东权益： | |||||||
| 普通股(元) | 34,000.00 | 34,000.00 | 34,000.00 | 34,000.00 | 34,000.00 | 25,000.00 | 25,000.00 |
| 股本溢价(元) | 516,920,000.00 | 513,926,000.00 | 510,591,000.00 | 507,133,000.00 | 504,725,000.00 | 444,588,000.00 | 441,914,000.00 |
| 留存收益(元) | -425,077,000.00 | -396,049,000.00 | -368,399,000.00 | -343,082,000.00 | -316,777,000.00 | -295,474,000.00 | -273,217,000.00 |
| 累计其他全面收益(元) | -3,294,000.00 | -3,465,000.00 | -2,891,000.00 | -3,060,000.00 | -3,541,000.00 | -5,326,000.00 | -4,150,000.00 |
| 归属于母公司股东权益(元) | 88,583,000.00 | 114,446,000.00 | 139,335,000.00 | 161,025,000.00 | 184,441,000.00 | 143,813,000.00 | 164,572,000.00 |
| 股东权益合计(元) | 88,583,000.00 | 114,446,000.00 | 139,335,000.00 | 161,025,000.00 | 184,441,000.00 | 143,813,000.00 | 164,572,000.00 |
| 负债及股东权益合计(元) | 113,968,000.00 | 138,743,000.00 | 160,332,000.00 | 183,202,000.00 | 203,468,000.00 | 162,838,000.00 | 182,319,000.00 |
| 公告日期 | 2024-03-11 | 2023-12-07 | 2023-09-07 | 2023-07-10 | 2023-03-09 | 2022-12-08 | 2022-09-08 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||
| 核数师 |